Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 12/2017

01-11-2017 | Gastrointestinal Oncology

Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database

Authors: Haejin In, MD, MBA, MPH, I. Solsky, MD, B. Palis, MA, M. Langdon-Embry, MS, J. Ajani, MD, T. Sano, MD, PhD

Published in: Annals of Surgical Oncology | Issue 12/2017

Login to get access

Abstract

Background

The 8th edition AJCC gastric cancer staging manual was refined using Japanese and Korean data from the International Gastric Cancer Association (IGCA). This study evaluated the eighth edition’s validity for U.S. populations.

Methods

National Cancer Database (NCDB) was used to obtain data on gastric cancer patients diagnosed from 2004 to 2008 who underwent surgery and to examine differences in stage grouping and survival between AJCC 7th and 8th editions. Discrimination of models derived from NCDB and IGCA data was compared.

Results

Of 12,041 patients, median age was 65, 57.6% were male, median lymph nodes retrieved was 2 (0–76), 30.9% underwent distal/partial gastrectomy, and 49.8% received no adjuvant treatment. The 8th edition differed in that T1–T3 disease was upstaged with N3b, T4aN3a was downstaged from IIIC to IIIB, and T4bN0 and T4aN2 were downstaged from IIIB to IIIA. These changes resulted in increased patients in IIIA (1436 in the 7th edition to 2310 in the 8th) and IIIB (1737–1896) and decreased in IIIC (2100–1067). This also resulted in lower median survival for IIIA (28.7–25.0 months), IIIB (19.6–17.4), IIIC (13.7–11.8). The concordance index for the 8th edition applied to NCDB data was 0.719 [95% confidence interval (CI) 0.703–0.734), which is comparable to that for the 8th edition developed from IGCA data (0.775, 95% CI 0.770–0.780) and the 7th edition applied to NCDB data (0.720, 95% CI 0.704–0.735).

Conclusions

The 8th edition is valid for U.S. populations, showing clear separation of data with preservation of group order.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Sano T, Coit DG, Kim HH, Roviello F, Kassab P, Wittekind C, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer. 2016; 20:217–225.CrossRefPubMed
4.
5.
Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683–90.CrossRefPubMedPubMedCentral
6.
7.
8.
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD Statement. Ann Intern Med. 2015;162:55–63. doi:10.​7326/​M14-0697.CrossRefPubMed
9.
McGhan LJ, Pockaj BA, Gray RJ, Bagaria SP, Wasif N. Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma. J Gastrointest Surg. 2012; 16(1):53–61; discussion 61.CrossRefPubMed
10.
Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077–9.CrossRefPubMed
11.
Ahn HS, Lee HJ, Hahn S, Kim WH, Lee KU, Sano T, et al. Evaluation of the seventh American joint committee on cancer/international union against cancer classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer. 2010;116(24):5592–98.CrossRefPubMed
12.
Marano L, Boccardi V, Braccio B, Esposito G, Grassia M, Petrillo M, et al. Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the “N” parameter-related survival: the monoinstitutional NodUs Italian study. World J Surg Oncol. 2015;13:215.CrossRefPubMedPubMedCentral
13.
14.
Palma DA. National Cancer Data Base: An important research tool, but not population-based. J Clin Oncol. 2017;35(5):571.CrossRef
15.
Deng J, Zhang R, Pan Y, Wang B, Wu L, Jiao X, et al. Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the tumor-node-metastasis (TNM) classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China. Surgery. 2014;156(1):64–74.CrossRefPubMed
16.
Reim D, Loos M, Vogl F, Novotny A, Schuster T, Langer R, et al. Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. J Clin Oncol. 2013;31(2):263–71.CrossRefPubMed
17.
Datta J, Lewis RS Jr, Mamtani R, Stripp D, Kelz RR, Drebin JA, et al. Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base. Cancer. 2014;120(18):2855–65.CrossRefPubMed
18.
Dubecz A, Solymosi N, Schweigert M, Stadlhuber RJ, Peters JH, Ofner D, et al. Time trends and disparities in lymphadenectomy for gastrointestinal cancer in the United States: a population-based analysis of 326,243 patients. J Gastrointest Surg. 2013;17(4):611–18.CrossRefPubMed
19.
Greenberg CC, Lipsitz SR, Neville B, In H, Hevelone N, Porter SA, et al. Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg. 2011;146(10):1128–34.CrossRefPubMedPubMedCentral
20.
Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, et al. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS ONE. 2012;7(11):e49424.CrossRefPubMedPubMedCentral
21.
Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, et al. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer. Hepato-gastroenterology. 2009;56(91–92):908–13.PubMed
22.
Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, et al. Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. J Gastrointest Surg. 2013;17(12):2059–66.CrossRefPubMed
23.
Lee JH, Kang JW, Nam BH, Cho GS, Hyung WJ, Kim MC, et al. Correlation between lymph node count and survival and a reappraisal of lymph node ratio as a predictor of survival in gastric cancer: a multi-instiutional cohort study. Eur J Surg Oncol. 2017;43(2):432–9.CrossRefPubMed
24.
Yamashita H, Deng J, Liang H, Seto Y. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positie gastric cancer patients. Surgery. 2017;161:1588–96.CrossRefPubMed
25.
Ajani JA, D’Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14(10):1286–312.CrossRefPubMed
26.
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. (editors) AJCC cancer staging manual. 8th ed. Cham: Springer International Publishing; 2017.
27.
Kattan MW, Hess KR, Amin MB, Lu Y, Moons KG, Gershenwald JE, et al. American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin. 2016;66(5):370–74.CrossRefPubMedPubMedCentral
Metadata
Title
Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database
Authors
Haejin In, MD, MBA, MPH
I. Solsky, MD
B. Palis, MA
M. Langdon-Embry, MS
J. Ajani, MD
T. Sano, MD, PhD
Publication date
01-11-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 12/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6078-x

Other articles of this Issue 12/2017

Annals of Surgical Oncology 12/2017 Go to the issue

Translational Research and Biomarkers

Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma

Head and Neck Oncology

Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy

Endocrine Tumors

Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors

Colorectal Cancer

A Multicenter Phase 2 Study on the Feasibility and Efficacy of Neoadjuvant Chemotherapy Without Radiotherapy for Locally Advanced Rectal Cancer

Gastrointestinal Oncology

Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy

Gastrointestinal Oncology

Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy